The strategic collaboration with Broad Clinical Labs will explore and develop applications using Roche’s SBX sequencing technology1, with an initial focus on critically ill newborns and their parents. Whole genome sequencing can help diagnose babies with suspected genetic disorders, such as cystic fibrosis and sickle cell disease. This project will explore how this technology could […]

New capital from Supernova Invest, alongside existing partners Elaia, Omnes, and Merieux Equity Partners, will accelerate SeqOne’s mission to transform genomic diagnostics worldwide, focusing on international expansion, U.S., and strategic growth. SeqOne, a pioneer in AI-driven genomic analysis for personalized medicine, today announced a significant €20 million oversubscribed growth funding round. Led by new investor […]

Partnership designed to expand QIAGEN’s leadership in oncology-focused digital PCR assays, advancing QIAcuity as the platform of choice for cancer research Combines QIAGEN’s global reach and automation expertise with ID Solutions’ assay development for research purposes and manufacturing strengths VENLO, Netherlands — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a new commercial partnership […]

The new facility will integrate the full chain of resources to accelerate new product launches, enable customized development, and better serve the Chinese market. The opening of the new headquarters will strengthen the collaboration of local team and capabilities, enabling even stronger alignment with Esco’s global expertise. SHANGHAI – Esco Lifesciences Group is proud to announce […]

Shimadzu Corporation invested in Persist AI Formulation Corp (Persist AI, based in California) through the Corporate Venture Capital (CVC) fund “Shimadzu Future Innovation Fund” (Shimadzu FIF). The company is developing a platform that utilizes AI and robotics to streamline the formulation of pharmaceuticals. The formulation process, which involves processing the pharmaceutical active ingredients into useful […]

Haorui’s established footprint brings HiFi sequencing to new customers including hospital labs and regional blood centers MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized leader in blood typing genomics, as an official distributor in China. The distribution […]

Offer end-to-end workflow from library prep through sequencing Twist to be sole provider of new Trinity™ library prep and target enrichment kits for Element AVITI™ sequencer Joint commercial activities to expand customer access to new NGS tools SOUTH SAN FRANCISCO, Calif. & SAN DIEGO —  Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity […]

UPPSALA, Sweden — MAGic BioProcessing (Lab-on-a-Bead AB) is pleased to announce the appointment of Jonathan Royce to its Board of Directors. Jonathan is a seasoned C-suite leader with over 25 years of leadership experience in the life sciences sector, with a strong track record spanning industrial biotechnology, development, production, and commercial strategy. He has lead teams at organizations […]

BOZEMAN, Mont. — Golden Helix today announced the release of VarSeq 3 and VSWarehouse 3, marking a major milestone in enterprise-scale secondary and tertiary genomic analysis. The release introduces cloud-native deployment options optimized for AWS and Azure, expanded support for hybrid and on-premise support, flexible licensing models including per-sample packaging tailored to small and mid-sized […]

DAEJEON, South Korea – Bioneer Corporation (KOSDAQ: 064550), a pioneering biotechnology company with over 30 years of expertise in molecular and synthetic biology, today announced significant advancements in its gene synthesis capabilities, highlighted by the features of its new MegaBase Synthesizer. This cutting-edge system dramatically boosts oligo pool production and offers enhanced cost-effectiveness, reinforcing Bioneer’s position […]